Across
- 2. - System involving hormones and their regulation.
- 3. - First-line drug for hyperthyroidism.
- 4. - Short-duration, rapid-acting insulin.
- 7. - Thiazolidinedione; improves glycemic control.
- 10. - Chronic condition characterized by high blood sugar.
- 13. - Long-duration insulin; clear solution.
- 15. - Meglitinide that promotes insulin secretion.
- 16. - Hormone regulating blood glucose levels.
- 18. - Simple sugar; vital for energy.
- 19. - SGLT-2 inhibitor; increases glucose excretion.
- 20. - Low blood sugar; potential risk of Sulfonylureas.
- 22. - GLP-1 agonist; slows gastric emptying.
- 23. - DPP-4 inhibitor enhancing incretin action.
Down
- 1. - Thiazolidinedione; restricted use.
- 5. - Inhibits thyroid hormone synthesis.
- 6. - Reduces glucose levels by decreasing resistance.
- 8. - Delays carbohydrate absorption.
- 9. - Condition related to kidney failure; affects drug metabolism.
- 10. - Hyperglycemic agent for hypoglycemic emergencies.
- 11. Acidosis - Potential side effect of Metformin.
- 12. - Biguanide, decreases liver glucose production.
- 13. - Sulfonylurea that stimulates insulin release.
- 14. - Slower-acting unmodified human insulin.
- 17. - Intermediate-duration insulin; cloudy solution.
- 18. - Sulfonylurea promoting insulin secretion.
- 21. - Drug of choice for hypothyroidism.
